Ezra M. Friedberg, Director at Pelthos Therapeutics Inc. (PTHS), sold 558 shares at $20.51 ($12K) on 2026-04-02, disclosed to the SEC on 2026-04-06.
Scheduled sale ($12k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.51 | 293 | $6K | 51.5% |
| 2 | $21.36 | 265 | $6K | 48.5% |
| Total | $20.92 avg | 558 | $12K | 100% |
| Filing → |
| PTHS | SELL | 2025-11-26 | $280K | — | Filing → |
| CHRO | BUY | 2024-03-12 | $100K | — | Filing → |